ORPHA:3451
West syndrome
Also known as: Intellectual disability-hysarrhytmia syndrome
Publications
9,943
Trials
29
Interventional, condition-specific
Researchers
1,169
Distinct authors in sample
Gene link
BRWD3
Limited
Readiness
6/6
Stages with a signal
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0018097
- UMLS:C0037769
- NCIT:C84788
Additional Mondo synonyms (6)
IESS · West's syndrome · infantile epileptic spasms syndrome · infantile spasms · infantile spasms syndrome · intellectual disability-hypsarrhythmia syndrome
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
6/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedPresent
Limited — BRWD3
- LiteraturePresent
9,943 matched papers (5,277 in last 10 years) Source
- Phenotype characterisedPresent
220 HPO annotations (e.g. Hypsarrhythmia; Abnormality of the nervous system; Abnormal skin morphology) Source
- Animal modelPresent
2 genotype models (Mus musculus) Source
- Orphan designationPresent
1 FDA · 3 EMA designations (1 FDA orphan-indication approval) — e.g. tricaprilin Source
- Interventional trialPresent
29 matched on ClinicalTrials.gov (3 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Possibly — only limited evidence so far for BRWD3.
GenCC classification: Limited.
Phenotypes (Monarch / HPO)
220
Associated phenotypes · MONDO:0018097
- Hypsarrhythmia
- Abnormality of the nervous system
- Abnormal skin morphology
- Developmental regression
- Myoclonus
Showing 5 of 220 — open Monarch for the full list.
Animal models (Monarch / Alliance)
2
Model associations linked to this Mondo ID
- Cdkl5tm1.2Cogr/Cdkl5tm1.2Cogr [background:] involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6J·MGI:5574073·Mus musculus
- Cdkl5tm1.2Cogr/Y [background:] involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6J·MGI:5574074·Mus musculus
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
4
Designations · 1 with FDA orphan-indication approval
- FDA tricaprilinInfantile spasms Infantile spasms · 2020-10-27 · Not FDA Approved for Orphan Indication
- EMA cannabidiolTreatment of West syndrome · 16/10/2017 · PositiveEMA designation
- EMA tricaprilinTreatment of West syndrome · 11/11/2022 · PositiveEMA designation
- EMA unknownTreatment of West syndrome · 09/02/2012 · WithdrawnEMA designation
Sources: FDA OOPD · EMA orphan designations
Open Targets candidates
18
Drugs / clinical candidates · MONDO_0018097
- CANNABIDIOL·phase 3
- COSYNTROPIN·phase 3
- PREDNISOLONE·phase 3
- PYRIDOXINE·phase 3
- CARBAMAZEPINE·phase 2
- FENFLURAMINE·phase 2
- JBPOS-0101·phase 2
- NITRAZEPAM·phase 2
- RADIPRODIL·phase 2
- VALPROIC ACID·phase 2
- BLARCAMESINE·phase 1
- BLARCAMESINE HYDROCHLORIDE·phase 1
- CPP-115·phase 1
- TRICAPRILIN·phase 1
- CORTICOTROPIN·approval
CTD chemicals (MyDisease.info)
17 associated chemicals · 105 pathways. Therapeutic evidence is listed first when present — not a treatment recommendation.
- Adrenocorticotropic Hormone · therapeutic
- adrenocorticotropin zinc · therapeutic
- Clobazam · therapeutic
- Clonazepam · therapeutic
- Cosyntropin · therapeutic
- Dexamethasone · therapeutic
- Phenobarbital · therapeutic
- Prednisone · therapeutic
- Primidone · therapeutic
- Valproic Acid · therapeutic
- Vigabatrin · therapeutic
- Betamethasone · marker/mechanism
Pathways: Primary bile acid biosynthesis; Pyrimidine metabolism; beta-Alanine metabolism; Pantothenate and CoA biosynthesis; Drug metabolism - other enzymes; Metabolic pathways; Phospholipase D signaling pathway; p53 signaling pathway
Literature
Is anyone studying this?
9,943
9,943 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
9,943 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
5,277 in the last 10 years · low confidence
Phrase hits: 9,508 · MeSH hits: 0
Who's working on it?
1,169
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Hussain SA10 papers · 2026
Division of Pediatric Neurology, Department of Pediatrics, UCLA Mattel Children's Hospital, David Geffen School of Medicine, Los Angeles, California, USA.
Papers in Europe PMC - 02Sahu JK10 papers · 2026
Pediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Papers in Europe PMC - 03Samanta D8 papers · 2026
University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Papers in Europe PMC - 04Wang J8 papers · 2026
Senior Department of Pediatrics, Chinese PLA General Hospital, Beijing, China.
Papers in Europe PMC - 05Matsuura R7 papers · 2026
Division of Neurology, Saitama Children's Medical Center, Saitama, Japan.
Papers in Europe PMC - 06Hamano SI6 papers · 2026
Division of Neurology, Saitama Children's Medical Center, Saitama, Japan; Department for Child Health and Human, Saitama Children's Medical Center, Saitama, Japan.
Papers in Europe PMC - 07Jain P6 papers · 2026
Division of Neurology, Department of Pediatrics, The Hospital for Sick Children (University of Toronto), Toronto, Ontario, Canada.
Papers in Europe PMC - 08Madaan P6 papers · 2026
Pediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Papers in Europe PMC - 09Shrey DW6 papers · 2026
Division of Neurology, Orange California & Department of Pediatrics, Children's Hospital of Orange County, UC Irvine, Orange, California, U.S.A.
Papers in Europe PMC - 10Wan L6 papers · 2026
Department of Pediatrics, The First Medical Center, Chinese PLA General Hospital, Beijing, China.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
29
interventional trials for this specific condition
29 interventional trials matched this specific condition name; 3 currently recruiting in our sample.
Data as of 11 September 2026 · last trial check 28 July 2026
29 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 95.9th percentile).
low confidence · 95.9th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
29 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT04289467·RECRUITING·Treatment of Refractory Infantile Spasms With Fenfluramine
Not reviewed·Conditions: Infantile Spasm·Matched via name phrase
- NCT06819670·RECRUITING·A Study to Prevent Infantile Spasms Relapse
Not reviewed·Conditions: Infantile Spasms · Infantile Epileptic Spasms Syndrome · West Syndrome·Matched via name phrase
- NCT04302116·RECRUITING·Vigabatrin With High Dose Prednisolone Combination Therapy vs Vigabatrin Alone for Infantile Spasm
Not reviewed·Conditions: Infantile Spasm · West Syndrome·Matched via name phrase
Observational and natural-history studies
8 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT05126914·RECRUITING·Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents
Not reviewed·Conditions: Epilepsy · West Syndrome · Dravet Syndrome·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 40 · after dedupe 40 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 40 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (40)
- isrctn·ISRCTN66692567·Not yet recruiting·A study of brain activity in visual snow syndrome and migraine
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15819396·Recruiting·A Phase I/IIa trial of KJ-103 in solid cancers
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15375673·Recruiting·Long Covid and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) study
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN56505721·Not yet recruiting·Myoinositol in adolescent polycystic ovary syndrome
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN23887564·Recruiting·The effect of digital cognitive behavioural therapy for insomnia on physical activity in fibromyalgia
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN39379437·Recruiting·A study of guselkumab versus risankizumab in participants with moderately to severely active Crohn's Disease
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN29145021·Recruiting·Assessing the appropriate duration of treatment for patients diagnosed with a blood clot in the their left heart chamber
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17931168·No longer recruiting·Impact of Symprove in Ehlers-Danlos Syndrome
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN42617850·Recruiting·Phase III study of revumenib in combination with intensive chemotherapy in newly diagnosed NPM1-mutated AML
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12271587·Recruiting·A Phase III randomized, open-label study of pasritamig (JNJ-78278343), a T-cell-redirecting agent targeting human kallikrein 2, with docetaxel versus docetaxel for metastatic castration-resistant prostate cancer
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17289436·Recruiting·A population-based digital study offering people testing for cancer genes, to identify people at increased risk of cancer so they can take steps to prevent it or detect it early
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN84044406·No longer recruiting·A Phase I trial of LY3143921 hydrate in solid tumours
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN53835117·No longer recruiting·The use of a new virtual reality software in psychiatric inpatient wards
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN90309905·Recruiting·ViTaL02: A study of a new vaccine against Lassa
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN57715622·Stopped·Evaluation of digital microfluidic molecular point-of-care testing for the diagnosis of respiratory pathogens
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN21010160·No longer recruiting·Bedside nose-to-intestine feeding with easily digested liquid nutrition for adults with acute respiratory distress and bleeding in the upper stomach or gut
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN29596999·No longer recruiting·Helping people with severe mental illness lower their risk of heart disease through peer support groups
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11396451·Enrolling by Invitation·Dietary approaches to the management of polycystic ovary syndrome trial
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15326567·Recruiting·Defining how antibiotics disrupt lung immune responses in asthma and health
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16084957·No longer recruiting·VITAL01: A study of a new vaccine against Lassa fever in adults aged 18-55 years
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10116165·Recruiting·DEsogestrel for Bleeding on the Implant (DEBI)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN73588250·No longer recruiting·The purpose of the trial is to test the safety, tolerability and efficacy of the drug tildacerfont, that is being developed for the treatment of major depressive disorder
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16740838·No longer recruiting·Comparison of X-Breathe HFNC Neo™ high-flow nasal cannula versus standard continuous positive airway pressure in late preterm neonates with respiratory distress
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN86229394·No longer recruiting·Early diagnosis of Stickler syndrome using a screening tool in children with Perthes disease
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN18208768·Recruiting·Security and effectiveness assessment of locking systems in ventriculostomy for traumatic brain injury
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for West syndrome — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("West syndrome" OR "Intellectual disability-hysarrhytmia syndrome" OR "West's syndrome" OR "infantile epileptic spasms syndrome" OR "infantile spasms" OR "infantile spasms syndrome" OR "intellectual disability-hypsarrhythmia syndrome") OR ("BRWD3" OR "BRWD3 syndrome" OR "BRWD3-related")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"West syndrome" OR "Intellectual disability-hysarrhytmia syndrome" OR "West's syndrome" OR "infantile epileptic spasms syndrome" OR "infantile spasms" OR "infantile spasms syndrome" OR "intellectual disability-hypsarrhythmia syndrome"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 29 interventional · 8 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: IESS
Confidence reasoning
- Preferred label is short or not clearly distinctive
- 1 synonym(s) dropped by stoplist (may under-count)
- "infantile epileptic spasms syndrome" also appears on ORPHA:697160
Ingested 2026-07-26T23:13:14.800Z
